Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prevail Global Study

NCT: NCT06535854 · RECRUITING

NCT IDNCT06535854

StatusRECRUITING

Start Date2025-02-24

SponsorMedtronic Vascular (INDUSTRY)

First posted2024-08-02

Last updated2026-10-21

Brief Summary

The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑